ARGENX SE
SEC registrant with listed symbol(s): ARGX (Nasdaq). This is a filing-identity record, not a verified operating-company profile.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- ARGX [1]
- Listing exchanges
- Nasdaq [1]
- SEC industry
- Biological Products, (No Diagnostic Substances) [1]
- Company / filing name
- ARGENX SE [1]
- Business address
- INDUSTRIEPARK ZWIJNAARDE 7, BUILDING C B-9052, ZWIJNAARDE [1]
- Incorporation jurisdiction
- Netherlands [1]
- Fiscal year end
- December 31 (SEC record) [1]
- CIK
- 0001697862 [1]
- SIC code
- 2836 [1]
Company positioning and business
SEC registrant with listed symbol(s): ARGX (Nasdaq). This is a filing-identity record, not a verified operating-company profile. [2]
The SEC classifies ARGENX SE under Biological Products, (No Diagnostic Substances) (SIC 2836). Its reported business address is INDUSTRIEPARK ZWIJNAARDE 7, BUILDING C B-9052, ZWIJNAARDE. Industry classification does not establish its full product range. [1]
Financial year, securities and disclosures
The SEC submissions record gives ARGENX SE a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: ARGX (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Form 20-F filed; reporting period ends 2025-12-31. [3]
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2836. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
Which industry classification does the SEC report for ARGENX SE?
The submissions record lists Biological Products, (No Diagnostic Substances), SIC 2836. [1]
Where can the financial reports of ARGENX SE be read?
The financial disclosures section links to collected annual, quarterly and current reports. The SEC source provides the broader filing record. [2]
ARGENX SE relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — ARGENX SE filing identity and securities ↗
- Exchange / company source ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.